Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/07/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2287 publications
Clinical characteristics, efficacy and safety of antifibrotic agents in elderly patients with connective tissue disease-associated interstitial lung disease
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: December 16, 2025
Nerandomilast (Jascayd) for idiopathic pulmonary fibrosis.
Journal: The Medical letter on drugs and therapeutics
Published: December 15, 2025
Structure-Based Optimization of Imidazopyridine Derivatives as Selective and Orally Bioavailable Phosphodiesterase 10A Inhibitors with Reduced Blood-Brain Barrier Penetration for the Treatment of Idiopathic Pulmonary Fibrosis.
Journal: Journal of medicinal chemistry
Published: November 21, 2025
Monocyte Subset Predicts Clinical Outcomes in Fibrotic Hypersensitivity Pneumonitis.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
The epigenetic roles of pirfenidone - implication in liver disease management.
Journal: Epigenomics
Published: October 25, 2025
Quantitative CT Analysis Reveals Stability of RA-ILD in Patients Treated with Pirfenidone: Insights from the TRAIL1 Trial.
Journal: American journal of respiratory and critical care medicine
Published: October 14, 2025
In vitro assessment of pirfenidone anti-fibrotic properties in a humanized 3D bioprinted kidney tubulointerstitium model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 03, 2025
Refractory Spontaneous Pneumothorax in Interstitial Lung Disease Under Pirfenidone Treatment.
Journal: Respirology case reports
Published: October 02, 2025
Tweaking the complex fibrogenic role of lymphocytes in IPF.
Journal: Tuberculosis and respiratory diseases
Published: September 29, 2025
Maintenance of Effectiveness of Pirfenidone in Elderly Patients with Progressive Functional Impairment: A Real-World Retrospective Study in IPF.
Journal: Biomedicines
Published: September 29, 2025
Photodynamic therapy with a novel photosensitizer inhibits BLM-induced pulmonary fibrosis in mice via MRC1-mediated pathway.
Journal: Frontiers in pharmacology
Published: September 27, 2025
Last Updated: 01/07/2026